GW & Wade’s iShares Core 60/40 Balanced Allocation ETF AOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.58M Sell
48,562
-4,726
-9% -$239K 0.08% 150
2023
Q3
$2.63M Buy
53,288
+2,826
+6% +$144K 0.1% 134
2023
Q2
$2.6M Sell
50,462
-2,545
-5% -$128K 0.09% 137
2023
Q1
$2.65M Sell
53,007
-4,380
-8% -$215K 0.1% 131
2022
Q4
$2.71M Buy
57,387
+15,686
+38% +$738K 0.11% 125
2022
Q3
$1.87M Buy
41,701
+3,344
+9% +$162K 0.09% 137
2022
Q2
$1.84M Hold
38,357
0.08% 149
2022
Q1
$2.07M Sell
38,357
-815
-2% -$44.4K 0.09% 131
2021
Q4
$2.24M Hold
39,172
0.1% 126
2021
Q3
$2.17M Buy
39,172
+1,144
+3% +$64.5K 0.1% 126
2021
Q2
$2.13M Buy
38,028
+385
+1% +$21.3K 0.1% 126
2021
Q1
$2.02M Buy
37,643
+10,524
+39% +$560K 0.11% 117
2020
Q4
$1.42M Buy
+27,119
New +$1.36M 0.09% 118

Other funds holding AOR

GW & Wade's AOR Position: Q4 2023 in Review

GW & Wade reduced its iShares Core 60/40 Balanced Allocation ETF (AOR) stake by 8.9% in Q4 2023, selling an estimated $239K and leaving 48,562 shares worth $2.58M. The position accounts for 0.08% of the portfolio, ranked #150.

GW & Wade first reported a position in AOR in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.71M in Q4 2022. 339 funds tracked by Wall St. Rank hold AOR as of Q4 2023.

  • GW & Wade held 48,562 shares of iShares Core 60/40 Balanced Allocation ETF worth $2.58M as of Q4 2023.
  • GW & Wade sold 4,726 iShares Core 60/40 Balanced Allocation ETF shares in Q4 2023, an estimated $239K.
  • iShares Core 60/40 Balanced Allocation ETF made up 0.08% of GW & Wade's portfolio in Q4 2023, its #150 holding.
  • GW & Wade first reported a position in iShares Core 60/40 Balanced Allocation ETF in Q4 2020 and has held it in 13 quarters since.
  • GW & Wade's iShares Core 60/40 Balanced Allocation ETF position peaked at $2.71M in Q4 2022.
  • 339 funds tracked by Wall St. Rank held iShares Core 60/40 Balanced Allocation ETF as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.